Biotech

All Articles

Pfizer takes $230M struck after axing fell short DMD gene therapy

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy failing has blown a $230 million gap ...

AC Immune sees 'spots' prospective in Alzheimer's medicine data

.After more than two decades of service neurodegenerative illness, Swiss biotech hvac Immune insuran...

GSK drops ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has actually broken up a period 2 individual papillomavirus (HPV) vaccine coming from its pipel...

OS Therapies refiles $6M IPO to fund HER2 medicine, preclinical ADCs

.OS Therapies are going to detail on the NYSE American supply exchange this morning using a $6.4 mil...

ALX's waning CD47 reaction cost delivers inventory spiraling down

.ALX Oncology's period 2 stomach cancer cells reaction cost has actually compromised. After observin...

Ionis centers eye illness coming from aim ats of Roche-partnered prospect after information dissatisfy

.One More of Ionis Pharmaceuticals' vital midphase readouts has actually disappointed assumptions, c...

Biogen's CEO claimed no unsafe deals in 2023. He's ready to be vibrant

.While Biogen's pharma peers are actually seeking for late-stage assets along with little bit of ris...

Instil refills pipeline in $2B biobucks take care of ImmunOnco

.Instil Bio has actually been actually a biotech trying to find a pipeline after it scrapped its lea...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually handed back liberties to an early Alzheimer's condition plan to Denali Therapeu...

Takeda water faucets brand new mind people oncology business-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of considerable management hirings, shooting...